PMV Pharmaceuticals (PMVP) News Today → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free PMVP Stock Alerts $1.80 +0.07 (+4.03%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - April 19 at 9:47 AMPMV Pharmaceuticals (PMVP) Price Target Increased by 45.83% to 8.93msn.com - April 18 at 12:37 AMPMV Pharmaceuticals (NASDAQ:PMVP) Now Covered by Jefferies Financial Groupamericanbankingnews.com - April 14 at 5:14 AMJefferies Financial Group Initiates Coverage on PMV Pharmaceuticals (NASDAQ:PMVP)marketbeat.com - April 12 at 8:23 AMPMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumorsglobenewswire.com - March 27 at 8:00 AMPMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancerfinance.yahoo.com - March 18 at 4:48 PMPMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women's Cancerglobenewswire.com - March 18 at 4:01 PMPMVP Apr 2024 5.000 callfinance.yahoo.com - March 16 at 9:41 AMHC Wainwright Research Analysts Lift Earnings Estimates for PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)marketbeat.com - March 11 at 1:45 AMHC Wainwright Reaffirms "Buy" Rating for PMV Pharmaceuticals (NASDAQ:PMVP)marketbeat.com - March 7 at 8:21 AMRTW Investments LP Sells 653,766 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)marketbeat.com - March 6 at 11:01 AMAlkeon Capital Management LLC Acquires 867,547 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)marketbeat.com - March 3 at 11:41 AMPMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlightsfinanznachrichten.de - March 3 at 12:04 AMOppenheimer Keeps Their Hold Rating on PMV Pharmaceuticals (PMVP)markets.businessinsider.com - March 1 at 3:02 PMPMV Pharmaceuticals Inc (PMVP) Reports Full Year 2023 Financial Resultsfinance.yahoo.com - March 1 at 3:02 PMTD Cowen Reaffirms Their Buy Rating on PMV Pharmaceuticals (PMVP)markets.businessinsider.com - March 1 at 12:04 AMPMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlightsglobenewswire.com - February 29 at 4:01 PMPMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conferencefinance.yahoo.com - February 26 at 12:29 PMCitigroup Inc. Has $2.25 Million Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)marketbeat.com - February 24 at 4:51 AMPMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runwayfinanznachrichten.de - January 19 at 9:10 AMPMV Phamra to Prioritize PC14586 Clinical Development, Will Cut Staff by 30%marketwatch.com - January 18 at 6:53 PMPMV to focus on lead drug, slashes workforce by 30%msn.com - January 18 at 6:53 PMPMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runwayfinance.yahoo.com - January 18 at 6:53 PMPMV Pharmaceuticals names Michael Carulli as CFOmsn.com - January 5 at 5:37 PMPMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Developmentfinance.yahoo.com - January 5 at 5:37 PMLadenburg Thalmann starts PMV Pharmaceuticals at buymsn.com - December 28 at 8:26 PMPMV Pharma Stock (NASDAQ:PMVP), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 28 at 3:26 PMPMV Pharma Stock (NASDAQ:PMVP), Short Interest Reportbenzinga.com - December 27 at 5:31 PMLadenburg Thalmann Initiates Coverage of PMV Pharmaceuticals (PMVP) with Buy Recommendationmsn.com - December 27 at 5:31 PM2 Red-Hot Stocks Highlight Wednesday's Top Wall Street Upgrades and Downgradesmsn.com - December 27 at 12:31 PMGracell downgrade, Fusion upgrade: Wall Street's top analyst callsfinance.yahoo.com - December 27 at 12:31 PMLADENBURG THALM/SH SH Initiates Coverage on PMV Pharmaceuticals (NASDAQ:PMVP)marketbeat.com - December 27 at 7:06 AMPMV Pharmaceuticals: In A Stronger Position Now Than Before, At A Lower Priceseekingalpha.com - November 14 at 7:37 PMAnalysts Are Bullish on These Healthcare Stocks: Century Therapeutics (IPSC), Phathom Pharmaceuticals (PHAT)markets.businessinsider.com - November 10 at 10:01 PMPMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlightsfinanznachrichten.de - November 9 at 3:59 PMPMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlightsfinance.yahoo.com - November 9 at 10:46 AMPMV Pharmaceuticals Inc (PMVP) Reports Q3 2023 Financial Results and Corporate Updatesfinance.yahoo.com - November 9 at 10:46 AMPMV Pharmaceuticals Receives ‘Buy’ Rating Based on PYNNACLE Trial Results and Ongoing Cancer Research Progressmarkets.businessinsider.com - October 16 at 2:25 PMPMV Pharmaceuticals, Inc. (PMVP) Loses -70.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Cornerfinance.yahoo.com - October 16 at 2:25 PMPrecision Oncology PMV Pharmaceuticals Reveals Early Data From Cancer Study In Pretreated Patientsmsn.com - October 12 at 7:31 PMPMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutationfinance.yahoo.com - October 12 at 2:30 PMmarketbeat.com - October 12 at 12:35 PMPMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinarfinance.yahoo.com - October 11 at 1:59 PMWall Street Analysts See a 239.26% Upside in PMV Pharmaceuticals, Inc. (PMVP): Can the Stock Really Move This High?finance.yahoo.com - October 6 at 3:41 PM30,500 Shares in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Acquired by Denali Advisors LLCmarketbeat.com - September 29 at 6:43 AMPMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeuticsfinance.yahoo.com - September 20 at 6:46 PMPMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Purchased by Principal Financial Group Inc.marketbeat.com - September 3 at 4:26 AMWall Street Analysts Think PMV Pharmaceuticals, Inc. (PMVP) Could Surge 182.64%: Read This Before Placing a Betfinance.yahoo.com - August 30 at 4:28 PMPMV Pharmaceuticals, Inc. (PMVP)'s Technical Outlook is Bright After Key Golden Crossfinance.yahoo.com - August 29 at 6:21 PMPMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Sees Large Drop in Short Interestmarketbeat.com - August 28 at 3:22 AM Get PMV Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PMVP and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction … Stop right now and do these 3 things to protect yourself PMVP Media Mentions By Week PMVP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PMVP News Sentiment▼0.760.45▲Average Medical News Sentiment PMVP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PMVP Articles This Week▼21▲PMVP Articles Average Week Get PMV Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PMVP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Chimerix News BioXcel Therapeutics News Eton Pharmaceuticals News Oncolytics Biotech News Affimed News Hookipa Pharma News YS Biopharma News Spero Therapeutics News Clearside Biomedical News Aclaris Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PMVP) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMV Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
